NCT06726902

Brief Summary

The aim of this clinical trial is to evaluate and compare the effect of a newly designed air-polishing device (APD) using Erythritol, Glycine, and Trehalose air-polishing powders in nonsurgical periodontal therapy with control (conventional scaling and root planning) following the concept of guided biofilm therapy (GBT) as an adjunctive to subgingival instrumentation (SI) in nonsurgical periodontal therapy for Stage II and III periodontitis patients both clinically and microbiologically.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

December 6, 2024

Last Update Submit

December 9, 2024

Conditions

Keywords

GBTPeriodontitisSI

Outcome Measures

Primary Outcomes (9)

  • Bleeding on probing

    up to six months

  • Pain Assessment

    Pain level will be assed using Visual Analogue Scale (VAS) from 1 (minimum) to 10 (maximum)

    up to six months

  • Probing depth

    up to six months

  • Plaque accumulation

    up to six months

  • Clinical attachment level

    up to six months

  • Microbiological Assessment of Aggregatibacter actinomycetemcomitans (Aa)

    one month

  • Microbiological Assessment of Porphyromonas gingivalis (Pg)

    one month

  • Microbiological Assessment of Tannerella forsythia (Tf)

    one month

  • Microbiological Assessment of Treponema denticola (Td)

    one month

Study Arms (4)

Test Group I (GBT and SI + erythritol powder)

EXPERIMENTAL

will receive GBT and SI with adjunctive air-polishing using Standard/ Subgingival nozzle + erythritol powder

Device: GBT and SI with erythritol powder

Test Group II (GBT and SI + glycine powder)

EXPERIMENTAL

will receive GBT and SI with adjunctive air-polishing using Standard/ Subgingival nozzle + glycine powder

Other: GBT and SI with glycine powder

Test Group III (GBT and SI + Trehalose powder)

EXPERIMENTAL

will receive GBT and SI with adjunctive air-polishing using Standard/ Subgingival nozzle + Trehalose powder

Other: GBT and SI with trehalose powder

Control Group VI (SRP and SI)

EXPERIMENTAL

will receive conventional Scaling and Root planning (SRP) and (SI) without adjunctive air polishing powder

Other: SRP and SI

Interventions

Non-Surgical Periodontal treatment: 1. Guided Biofilm Therapy * Guided supragingival and shallow subgingival (PD ≥ 4 mm) removal of biofilm and stains from all quadrants using the air-polishing device using a standard nozzle system. * Subgingival removal of biofilm from deeper periodontal pockets (PD ≥ 6 mm) using an Air-polishing device subgingival nozzle system with erythritol powder . 2. Scaling and root planing Scaling and root planing (SRP) For the control group, conventional scaling and root planning (SRP) only.

Also known as: guided biofilm therapy
Test Group I (GBT and SI + erythritol powder)

Non-Surgical Periodontal treatment: 1. Guided Biofilm Therapy • Guided supragingival and shallow subgingival (PD ≥ 4 mm) removal of biofilm and stains from all quadrants using the air-polishing device using a standard nozzle system. • Subgingival removal of biofilm from deeper periodontal pockets (PD ≥ 6 mm) using an Air-polishing device subgingival nozzle system with glycine powder. 2. Scaling and root planing Scaling and root planing (SRP) For the control group, conventional scaling and root planning (SRP) only

Test Group II (GBT and SI + glycine powder)

Non-Surgical Periodontal treatment: 1. Guided Biofilm Therapy • Guided supragingival and shallow subgingival (PD ≥ 4 mm) removal of biofilm and stains from all quadrants using the air-polishing device using a standard nozzle system. • Subgingival removal of biofilm from deeper periodontal pockets (PD ≥ 6 mm) using an Air-polishing device subgingival nozzle system with trehalose powder . 2. Scaling and root planing Scaling and root planing (SRP) For the control group, conventional scaling and root planning (SRP) only

Test Group III (GBT and SI + Trehalose powder)

conventional scaling and root planning (SRP) with subgingival instrumentation only will be performed

Control Group VI (SRP and SI)

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals of both sexes with an age between 30 and 65 years, having at least 16 natural teeth in function,
  • Stage II and III (moderate to severe) periodontitis, having at least 16 teeth with the need for SI
  • Interproximal plaque index (API) ≤ 35%; patients with Good oral hygiene.
  • No history of systemic disease that may influence periodontal disease

You may not qualify if:

  • Pregnancy or breastfeeding,
  • Smokers with more than seven cigarettes per day
  • Patients that had a treatment with antibiotics within six months before the study
  • Need for periodontal surgery or adjunctive antibiotic treatment to the SI
  • Patients who had any periodontal treatment during the last year before the study.
  • Patients with known systemic or autoimmune disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, 21923, Egypt

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Rania Abdelaziz Fahmy, PhD

    Alexandria University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Periodontology MSc. Candidate

Study Record Dates

First Submitted

December 6, 2024

First Posted

December 10, 2024

Study Start

March 3, 2024

Primary Completion

November 1, 2024

Study Completion

December 1, 2024

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
six month

Locations